<!doctype html><html><head><meta charset=utf-8><title>Synthetic EPA drug recommended to FDA for Cardio (Omega-3 is 8 X better)</title>
<link rel=stylesheet href="/css/main.css?v=1753303882"><link rel=stylesheet href="/css/pagination.css?v=1753303882"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src="/js/search-suggestions.js?v=1753303882"></script><script src="/js/search.js?v=1753303882"></script><script type=module>
        
        window.initPagefind = async function() {
            try {
                console.log('Loading Pagefind module...');
                window.pagefind = await import('/pagefind/pagefind.js');
                if (!window.pagefind) {
                    throw new Error('Failed to load Pagefind module - import returned empty result');
                }
                
                console.log('Initializing Pagefind...');
                const initResult = await window.pagefind.init();
                console.log('Pagefind loaded and initialized');
                
                
                if (window.searchInstance) {
                    console.log('Notifying Search instance of Pagefind initialization');
                    window.searchInstance.initializePagefind(window.pagefind);
                    console.log('Search instance successfully notified');
                } else {
                    console.warn('Search instance not found in global scope yet, but Pagefind is loaded');
                    
                }
            } catch (error) {
                console.error('CRITICAL ERROR: Failed to initialize Pagefind:', error);
                
                const errorDetails = error.stack || error.message || String(error);
                console.error('Error details:', errorDetails);
                
                
                const statusEl = document.querySelector('#search-status');
                const inputEl = document.querySelector('#search-input');
                
                if (statusEl) {
                    statusEl.textContent = 'Search unavailable: ' + error.message;
                    statusEl.style.display = 'block';
                    statusEl.style.color = 'red';
                }
                
                if (inputEl) {
                    inputEl.disabled = true;
                    inputEl.placeholder = 'Search unavailable';
                }
            }
        };
        
        
        window.pagefindInitialized = false;
        
        
        document.addEventListener('DOMContentLoaded', () => {
            console.log('DOM loaded, initializing Pagefind...');
            window.initPagefind();
        });
    </script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><div class=scroll-nav-top><a href=javascript:void(0); id=scroll-to-bottom class=scroll-button aria-label="Scroll to bottom" onclick='return window.scrollTo({top:document.body.scrollHeight,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 4a.5.5.0 01.5.5v5.793l2.146-2.147a.5.5.0 01.708.708l-3 3a.5.5.0 01-.708.0l-3-3a.5.5.0 11.708-.708L7.5 10.293V4.5A.5.5.0 018 4z"/></svg>
<span>Scroll to Bottom</span></a></div><h1>Synthetic EPA drug recommended to FDA for Cardio (Omega-3 is 8 X better)</h1><time>January 12, 2020</time><div data-pagefind-body><p><strong><i class="fas fa-file-pdf" style=margin-right:.3em></i><a href=https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/emdac-20191114-draftagenda.pdf>Download the FDA Meeting agenda from VitaminDWiki</a></strong></p><p><strong><i class="fas fa-file-pdf" style=margin-right:.3em></i><a href=https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/cardiovascular-risk-reduction-with-icosapent-ethyl-for-hypertriglyceridemia-nejm.pdf>Download the Study PDF from VitaminDWiki</a></strong></p><p>Synthetic EPA (Vascepa) contains zero DHA</p><p>2 grams twice a day for 5 years had frequent side effects of joint pain</p><p><strong>RESULTS Clipped from PDF</strong></p><p>“A total of 8179 patients were enrolled (70.7% for secondary prevention of cardiovascular events) and were followed for a median of 4.9 years. A primary end-point event occurred in 17.2% of the patients in the icosapent ethyl group, as compared with 22.0% of the patients in the placebo group (hazard ratio, 0.75; 95% confidence interval <span>[CI]</span>, 0.68 to 0.83; P&lt;0.001);…”</p><h4 id=reduction-of-cardiovascular-events>Reduction of Cardiovascular events</h4><ul><li><p>1.25 X reduction of risk with $380/month Synthetic EPA</p></li><li><p><a href=/posts/omega-3-is-vital-for-health-mail-in-test-is-low-cost-and-accurate>10 X reduction of risk when Omega-3 index is > 6</a></p></li><li><p>Thus a good level of Omega-3 provides <strong>8 X</strong> the benefit of synthetic EPA</p></li></ul><h4 id=note>Note</h4><ul><li><p>No direct comparison of EPA+DHA (Omega-3) with Synthetic EPA</p></li><li><p>The FDA only requires that a drug be safe and better than a placebo</p><ul><li>but not better than existing treatment or supplement</li></ul></li><li><p>FDA gets more than <a href=https://www.fda.gov/about-fda/fda-basics/fact-sheet-fda-glance>45% of its annual budget from Industry fees( Big Pharma)</a></p></li><li><p>Much more amount of money to be gained at many levels by prescribing a drug than by using a supplement</p></li><li><p><a href=/posts/fda-allows-2-specific-vitamin-d-and-2-omega-3-health-claims-2019>FDA now allows specific Omega-3 health claims – July 2019</a></p></li></ul><h4 id=huge-number-of-conflicts-of-interest-reported-in-the-pdf>Huge number of Conflicts of Interest reported in the PDF</h4><p><strong>Dr. Bhatt</strong> reports receiving grant support from Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Medtronic, Sanofi Aventis, The Medicines Company, Roche, Pfizer, Forest Laboratories/AstraZeneca, Ischemix, Amgen, Lilly, Chiesi, Ironwood, Abbott, Regeneron, PhaseBio, Idorsia, and Synaptic, <strong>fees</strong> for serving on CME steering committees from WebMD, advisory board <strong>fees</strong> from Elsevier, <strong>fees</strong> for serving on the board of directors from TobeSoft, <strong>fees</strong> for serving on an executive steering committee (with payments from Baim Institute Clinical Research) and for editorial support service from Boehringer Ingelheim, and <strong>fees</strong> for serving on the operations committee, on the publications committee, on a steering committee (with payments from Population Health Research Institute), and as the USA co–national leader from Bayer, unfunded research collaborations with FlowCo, Novo Nordisk, Plx Pharma, Takeda, and Merck, and serving on advisory boards for Medscape Cardiology, Regado Biosciences, and Cardax and as site co-investigator for St. Jude Medical (now Abbott), Biotronik, Boston Scientific, and Svelte;</p><p><strong>Dr. Steg</strong> , receiving grant support and <strong>fees</strong> for serving on a steering committee from Bayer/Janssen, grant support and lecture <strong>fees</strong> from Merck, grant support, <strong>fees</strong> for serving as co-chair of the ODYSSEY outcomes trial and as co-chair of the SCORED trial, consulting <strong>fees</strong> , and lecture <strong>fees</strong> from Sanofi, consulting <strong>fees</strong> and lecture <strong>fees</strong> from Amgen, consulting <strong>fees</strong> , lecture <strong>fees</strong> , and <strong>fees</strong> for serving on an event committee from Bristol-Myers Squibb, <strong>fees</strong> for serving on an executive steering committee from Boehringer Ingelheim, <strong>fees</strong> for serving on an event committee from Pfizer, consulting <strong>fees</strong> and <strong>fees</strong> for serving on an executive steering committee from Novartis, consulting <strong>fees</strong> from Regeneron and Lilly, consulting <strong>fees</strong> and <strong>fees</strong> for serving as co-chair of the THEMIS trial from AstraZeneca, and grant support and <strong>fees</strong> for serving as chair of the data and safety monitoring committee for the ATPCI trial and as chair of the CLARIFY registry from Servier;</p><p><strong>Dr. Brinton</strong> , receiving lecture <strong>fees</strong> from Boehringer, Janssen, Kaneka, and Novo Nordisk, consulting <strong>fees</strong> and lecture <strong>fees</strong> from Amarin, Amgen, AstraZeneca, Akcea, Kastle, Kowa, Merck, Sanofi, and Regeneron, and consulting <strong>fees</strong> from Arisaph, Denka-Seiken, Esperion, Medicure, Precision Biosciences, and PTS Diagnostics; Dr. Miller, receiving consulting <strong>fees</strong> from Amarin and Akcea; Dr. Jacobson, receiving consulting <strong>fees</strong> from AstraZeneca, Amgen, Novartis, Esperion, and Regeneron/Sanofi;</p><p><strong>Dr. Ketchum, Mr. Doyle, Dr. Juliano, Dr. Jiao, and Dr. Granowitz, being employed by and being a stock shareholder</strong> of Amarin Pharma;</p><p><strong>Dr. Tardif</strong> , receiving grant support from AstraZeneca, Esperion, and Ionis, grant support and consulting <strong>fees</strong> from DalCor, grant support and <strong>fees</strong> for serving as co-chairman of an executive committee from Pfizer, grant support and <strong>fees</strong> for serving on an executive committee from Sanofi, and grant support and consulting <strong>fees</strong> from Servier and holding a minor equity interest in DalCor and a patent (U.S. 9,909,178 B2) on Dalcetrapib for Therapeutic Use; and</p><p><strong>Dr. Ballantyne</strong> , receiving consulting <strong>fees</strong> from AstraZeneca, Eli Lilly, Matinas BioPharma, Merck, Boehringer Ingelheim, Novo Nordisk, Denka Seiken, and Gilead and grant support (paid to her institution) and consulting <strong>fees</strong> from Amarin, Amgen, Esperion, Novartis, Regeneron, Sanofi-Synthelabo, and Akcea</p></div><hr class=tag-separator><div class=tags><span>Tags: </span><a href=/tags/cardiovascular.html><span class=tag>Cardiovascular</span></a>
<a href=/tags/omega-3.html><span class=tag>omega 3</span></a>
<a href=/tags/omega-3-and-viruses.html><span class=tag>omega 3 and viruses</span></a>
<a href=/tags/omega-3.html><span class=tag>Omega-3</span></a>
<a href=/tags/pfizer.html><span class=tag>pfizer</span></a>
<a href=/tags/virus.html><span class=tag>virus</span></a></div><div data-pagefind-meta=tags hidden>Cardiovascular, omega 3, omega 3 and viruses, Omega-3, pfizer, virus</div><div class=scroll-nav-bottom id=article-bottom><a href=javascript:void(0); id=scroll-to-top class=scroll-button aria-label="Scroll to top" onclick='return window.scrollTo({top:0,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 12a.5.5.0 00.5-.5V5.707l2.146 2.147a.5.5.0 00.708-.708l-3-3a.5.5.0 00-.708.0l-3 3a.5.5.0 10.708.708L7.5 5.707V11.5a.5.5.0 00.5.5z"/></svg>
<span>Back to Top</span></a></div></article></div></div><script src="/js/toc-sanitizer.js?v=1753303882"></script><script src="/js/tiki-redirects.js?v=1753303882"></script><script src="/js/lightspa.js?v=1753303882"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1753303882",indexUrl:"/search/search_index.json.gz?v=1753303882"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/scroll-buttons.js?v=1753303882"></script></body></html>